UB Paderborn / Katalog / Suche / in CDI

Influence of Catumaxomab on Tumor Cells in Bone Marrow and Blood in Ovarian Cancer

Anticancer research, 2009-05, Vol.29 (5), p.1787-1791

2009

Volltextzugriff (PDF)

A pretreatment mass spectrometry-based serum proteomic test is able to stratify patients with ovarian cancer receiving adjuvant chemotherapy according to overall and progression-free survival and identify patients likely to exhibit chemoresistance

Gynecologic oncology, 2017-06, Vol.145, p.82-82

2017

Volltextzugriff (PDF)

Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome

Archives of gynecology and obstetrics, 2014-11, Vol.290 (5), p.1023-1030

2014

Volltextzugriff (PDF)

Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome

Human reproduction (Oxford), 2014-03, Vol.29 (3), p.518-524

2014

Volltextzugriff (PDF)

Cytomorphology of Circulating Colorectal Tumor Cells:A Small Case Series

Journal of oncology, 2010-01, Vol.2010, p.861341-7

2010

Volltextzugriff (PDF)

Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up

Archives of gynecology and obstetrics, 2015-11, Vol.292 (5), p.1117-1125

2015

Volltextzugriff (PDF)

Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients

Gynecological endocrinology, 2015-01, Vol.31 (1), p.26-30

2015

Volltextzugriff (PDF)

0189: Influence of Platinum-Based Chemotherapy On Disseminated Tumor Cells in Blood and Bone Marrow of Patients with Primary Ovarian Cancer

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.653-654

2006

Volltextzugriff (PDF)

Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response

Cancer management and research, 2019-01, Vol.11, p.9571-9583

2019

Volltextzugriff (PDF)

Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (7), p.2882-2889

2005

Volltextzugriff (PDF)

A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)

International journal of oncology, 2002-05, Vol.20 (5), p.1027

2002

Volltextzugriff (PDF)

Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

Breast cancer research and treatment, 2001-09, Vol.69 (2), p.123-132

2001

Volltextzugriff (PDF)

In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy

Experimental hematology, 1998-11, Vol.26 (12), p.1111-1117

1998

Volltextzugriff (PDF)

Abstract P2-01-06: Similarities and differences in RNA profiles of circulating tumor cells in breast cancer subtypes: Do we have therapeutic options?

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-01-06

2018

Volltextzugriff (PDF)

Abstract P1-01-09: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-01-09

2017

Volltextzugriff (PDF)

Abstract PD3-02: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD3-02-PD3-02

2018

Volltextzugriff (PDF)

Abstract P4-01-10: The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-01-10

2019

Volltextzugriff (PDF)

Abstract P6-09-08: High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-09-08

2019

Volltextzugriff (PDF)

Abstract P6-09-01: In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survival

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-09-01

2019

Volltextzugriff (PDF)

Abstract P2-02-05: Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profiles

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-02-05

2016

Volltextzugriff (PDF)

Abstract P2-02-01: In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcome

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-02-01

2016

Volltextzugriff (PDF)

Abstract P4-04-07: Association between tumor infiltrating immune cells and disseminated tumor cells in the bone marrow of patients with primary breast cancer: A ten year follow-up

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-04-07

2016

Volltextzugriff (PDF)

Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter

Perfusion, 2001, Vol.16 (1_suppl), p.51-55

2001

Volltextzugriff (PDF)

Abstract P6-07-11: Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-07-11

2017

Volltextzugriff (PDF)

Abstract P5-03-10: Development of a novel HER2 testing strategy, using image-based cell-sorting to isolate pure cell populations from FFPE upstream of FISH

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-03-10

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Influence of Catumaxomab on Tumor Cells in Bone Marrow and Blood in Ovarian Cancer

A pretreatment mass spectrometry-based serum proteomic test is able to stratify patients with ovarian cancer receiving adjuvant chemotherapy according to overall and progression-free survival and identify patients likely to exhibit chemoresistance

Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome

Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome

Cytomorphology of Circulating Colorectal Tumor Cells:A Small Case Series

Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up

Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients

0189: Influence of Platinum-Based Chemotherapy On Disseminated Tumor Cells in Blood and Bone Marrow of Patients with Primary Ovarian Cancer

Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response

Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct

A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)

Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy

Abstract P2-01-06: Similarities and differences in RNA profiles of circulating tumor cells in breast cancer subtypes: Do we have therapeutic options?

Abstract P1-01-09: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients

Abstract PD3-02: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients

Abstract P4-01-10: The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patients

Abstract P6-09-08: High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patients

Abstract P6-09-01: In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survival

Abstract P2-02-05: Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profiles

Abstract P2-02-01: In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcome

Abstract P4-04-07: Association between tumor infiltrating immune cells and disseminated tumor cells in the bone marrow of patients with primary breast cancer: A ten year follow-up

Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter

Abstract P6-07-11: Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow

Abstract P5-03-10: Development of a novel HER2 testing strategy, using image-based cell-sorting to isolate pure cell populations from FFPE upstream of FISH

Suchergebnisse filtern